Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 142

Results For "FDA"

1712 News Found

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent
Biotech | April 25, 2022

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
Public Health | April 22, 2022

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal

The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter


Dr. Reddy's launch Posaconazole delayed-release tablets in the US
Drug Approval | April 21, 2022

Dr. Reddy's launch Posaconazole delayed-release tablets in the US

The tablets are available in 100 mg strength in bottle count sizes of 60


CK Birla Hospital performs highest number of VABB surgeries in a year
Hospitals | April 21, 2022

CK Birla Hospital performs highest number of VABB surgeries in a year

Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


MicroGEM granted EUA for Covid-19 PCR Saliva test
Biotech | April 20, 2022

MicroGEM granted EUA for Covid-19 PCR Saliva test

The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes


Akron Bio completes plasmid DNA manufacturing facility
News | April 19, 2022

Akron Bio completes plasmid DNA manufacturing facility

The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets


Amneal achieves second U.S. biosimilars approval with Alymsys
Drug Approval | April 18, 2022

Amneal achieves second U.S. biosimilars approval with Alymsys

Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022


Geocann and Averix Bio to partner on API phytocannabinoid ingredients
News | April 18, 2022

Geocann and Averix Bio to partner on API phytocannabinoid ingredients

This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors